Screener
ResMed RMD Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by ResMed in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: ResMed’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 6:19 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000943819-26-000025
| Line item | March 31,2026 | June 30,2025 |
|---|---|---|
| Commitments and contingencies (note 9) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued | — | — |
| Common stock, $0.004 par value, 350,000,000 shares authorized; 190,866,303 issued and 145,040,224 outstanding at March 31, 2026 and 190,311,097 issued and 146,385,350 outstanding at June 30, 2025 | 763 | 761 |
| Additional paid-in capital | 2,134,231 | 2,033,599 |
| Retained earnings | 6,958,779 | 6,081,490 |
| Treasury stock, at cost, 45,826,079 shares at March 31, 2026 and 43,925,747 shares at June 30, 2025 | (2,576,957) | (2,073,292) |
| Accumulated other comprehensive loss | (24,905) | (74,699) |
Item 1. Financial Statements
FAQ
- What is ResMed's common stock, par value (in dollars per share)?
- ResMed (RMD) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has ResMed's common stock, par value (in dollars per share) changed year-over-year?
- ResMed's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for ResMed's common stock, par value (in dollars per share)?
- Over 4 years (2021 to 2025), ResMed's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.
Ask your AI about ResMed's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude